Your Location:
Home >
Browse articles >
Modified Erchentang Alleviates Inflammation in Chronic Obstructive Pulmonary Disease via Midkine/Notch2/Hey1 Signaling Pathway in Rats
Modified Erchentang Alleviates Inflammation in Chronic Obstructive Pulmonary Disease via Midkine/Notch2/Hey1 Signaling Pathway in Rats
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 16, Pages: 12-21(2023)
DOI: 10.13422/j.cnki.syfjx.20230741
Scan QR Code
Full Text(HTML)
Figs( 4 ) Tabs( 5 )
References
Publication Info
Metrics
244
Views
110
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Anti-inflammatory Mechanism of Modified Erchentang on Chronic Obstructive Pulmonary Disease Through Jagged1/Notch1/Hes1 Signaling Pathway
Effect of Modified Erchentang on Bronchioles of Rats with Chronic Obstructive Pulmonary Disease by HMGB1/RAGE/NF-κB Signaling Pathway
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
Erchentang Alleivates Depression in Obese Mice by Regulating PPAR Signaling Pathway
Network Pharmacology and Animal Experiments Reveal Mechanism of Daturae Flos in Ameliorating Chronic Obstructive Pulmonary Disease
Related Author
JI Shu
LI Yaoyang
HU Wenhao
CHEN Zhuang
LIU Gaoyang
SHANG Haofan
WANG Hongwei
WANG Qi
Related Institution
Henan Second Provincial People's Hospital
Hubei Shizhen Laboratory
Central Theater Command General Hospital of the People's Liberation Army
School of Basic Medical Sciences, Hubei University of Chinese Medicine
College of Traditional Chinese Medicine,Zhaoqing Medical College


